hrcak mascot   Srce   HID

Sažetak sa skupa

Amniotic membrane transplantation for severe ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Valentina Juraga ; School of Medicine University of Zagreb
Zinaida Perić ; School of Medicine University of Zagreb; Department of Hematology; University Hospital Centre Zagreb
Ivan Škegro
Nadira Duraković ; School of Medicine University of Zagreb; Department of Hematology; University Hospital Centre Zagreb
Lana Desnica ; Department of Hematology; University Hospital Centre Zagreb
Dražen Pulanić ; School of Medicine University of Zagreb;Department of Hematology; University Hospital Centre Zagreb
Radovan Vrhovac ; School of Medicine University of Zagreb; Department of Hematology; University Hospital Centre Zagreb

Puni tekst: engleski, pdf (66 KB) str. 0-0 preuzimanja: 10* citiraj
APA 6th Edition
Juraga, V., Perić, Z., Škegro, I., Duraković, N., Desnica, L., Pulanić, D. i Vrhovac, R. (2019). Amniotic membrane transplantation for severe ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Liječnički vjesnik, 141 (suppl.1), 0-0. Preuzeto s https://hrcak.srce.hr/225342
MLA 8th Edition
Juraga, Valentina, et al. "Amniotic membrane transplantation for severe ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation." Liječnički vjesnik, vol. 141, br. suppl.1, 2019, str. 0-0. https://hrcak.srce.hr/225342. Citirano 06.12.2019.
Chicago 17th Edition
Juraga, Valentina, Zinaida Perić, Ivan Škegro, Nadira Duraković, Lana Desnica, Dražen Pulanić i Radovan Vrhovac. "Amniotic membrane transplantation for severe ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation." Liječnički vjesnik 141, br. suppl.1 (2019): 0-0. https://hrcak.srce.hr/225342
Harvard
Juraga, V., et al. (2019). 'Amniotic membrane transplantation for severe ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation', Liječnički vjesnik, 141(suppl.1), str. 0-0. Preuzeto s: https://hrcak.srce.hr/225342 (Datum pristupa: 06.12.2019.)
Vancouver
Juraga V, Perić Z, Škegro I, Duraković N, Desnica L, Pulanić D i sur. Amniotic membrane transplantation for severe ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Liječnički vjesnik [Internet]. 2019 [pristupljeno 06.12.2019.];141(suppl.1):0-0. Dostupno na: https://hrcak.srce.hr/225342
IEEE
V. Juraga, et al., "Amniotic membrane transplantation for severe ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation", Liječnički vjesnik, vol.141, br. suppl.1, str. 0-0, 2019. [Online]. Dostupno na: https://hrcak.srce.hr/225342. [Citirano: 06.12.2019.]

Sažetak
Allogeneic stem cell transplantation (allo-SCT) offers cure to otherwise incurable hematologic malignancies, but can also lead to many infectious and immune complications, most importantly graft-versus-host disease (GVHD). Ocular GVHD (oGVHD) occurs in 40-60% of allo-SCT patients and can result in severe ocular surface disease causing vision impairment and deterioration of quality of life. Amniotic membrane transplantation (AMT) is an established technique in the treatment of various diseases of the ocular surface. This method could provide new options in the management of otherwise disabling severe oGVHD We describe a young female patient with myeloproliferative neoplasm who underwent allo-SCT from an unrelated donor and suffered from numerous post-transplant complications. In the early post-transplant period she developed acute skin and liver GVHD, requiring introduction of immunosupressive treatment with steroids. Steroid treatment was then complicated with miopathy, iatrogenic diabetes and many infections. She developed serious herpes virus (HSV) ophtalmitis followed by severe GVHD of the eye. Despite multiagent local therapy, oGVHD progressed to ocular ulcers with threatening corneal perforation. We hesitated from increasing systemic immunosupression due to severity of previous HSV reactivation. Therefore we decided to perform AMT which led to complete corneal healing and full clinical recovery. Moreover, there was no recurrence of severe oGVHD and the patient resumed her daily activities In conclusion, this case report serves as a foundation for further research of AMT possibilities. This procedure could become beneficial in the treatment of severe oGVHD, especially in patients at high risk for infectious complications and contraindication for systemic immunosuppression.

Ključne riječi
allogeneic, transplantation, GVHD, ocular

Hrčak ID: 225342

URI
https://hrcak.srce.hr/225342

Posjeta: 28 *